# The Cigna Group – Consensus ‘buy’ rating and 10.7% Upside Potential

- Link: https://www.directorstalkinterviews.com/the-cigna-group-consensus-buy-rating-and-10.7-upside-potential/4121152556
- Published: 2024-04-19T14:17:25+01:00
- Author: Charlotte Edwards

**The Cigna Group** with ticker code (CI) have now 21 analysts in total covering
the stock. The consensus rating is pointing to ‘buy’. The target price High/Low 
ranges between $420.00 and $348.00 calculating the average target price we see $
383.14. Now with the previous closing price of $346.08 this now indicates there 
is a potential upside of 10.7%. It’s also worth noting that there is a 50 day moving
average of $347.24 and the 200 day MA is $305.77. The company has a market capitalization
of 98.93B. The stock price is currently at: $348.78 USD

 The potential market cap would be $109,524,369,933 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 20.04, revenue per share of $664.15
and a 3.75% return on assets.

The Cigna Group is a global health services company. The Company’s portfolio of 
offerings solves diverse challenges across the healthcare system. The Company offers
a differentiated set of pharmacy, medical, behavioral, dental and supplemental products,
and services, primarily through two platforms: Evernorth Health Services and Cigna
Healthcare. Evernorth Health Services includes a range of coordinated and point 
solution health services and capabilities, as well as those from partners across
the health care system, in pharmacy benefits, home delivery pharmacy, specialty 
pharmacy, distribution, and care delivery and management solutions, which are provided
to health plans, employers, government organizations and health care providers. 
Cigna Healthcare includes the United States Commercial, United States Government,
and International Health operating segments, which provide medical and coordinated
solutions to clients and customers.

Share on:
